VERU INC. Advertising Expense
VERU INC. (VERU) reported Advertising Expense of $0 for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2025-12-17
- VERU INC. advertising expense for fiscal 2025 was $0.00.
- VERU INC. advertising expense for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- VERU INC. advertising expense for fiscal 2023 was $900.00K, a 50.00% increase from fiscal 2022.
- VERU INC. advertising expense for fiscal 2022 was $600.00K.
| Period end | Advertising Expense 12 month | Advertising Expense 12 month as first filed |
|---|---|---|
| 2025-09-30 | $0.00 10-K · filed 2025-12-17 | |
| 2024-09-30 | $0.00 10-K · filed 2025-12-17 | $800.00K 10-K · filed 2024-12-16 |
| 2023-09-30 | $900.00K 10-K · filed 2024-12-16 | |
| 2022-09-30 | $600.00K 10-K/A · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |